JamesClearly I don't, hence your input is appreciated, but there is a connection, mine is as a holder of the stock, yours is one of interest only or more?
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling